References
- Bohan A, Peter J B. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344–7
- Steele J C, Gladstone R M. Thanasophon S, Fleming P. Mycoplasma pneumoniae as a determinant of the Guillain-Barre syndrome. Lancet 1969; 2: 710–4
- Tanowitz H B, Robbins N, Leidich N. Hemolytic anemia. Associated with severe Mycoplasma pneumoniae pneumonia. NY State J Med 1978; 78: 2231–2
- Bowles N E, Sewry C A, Dubowitz V, Archard L C. Dermatomyositis, polymyositis, and coxsackie-B-virus infection. Lancet 1987; 1: 1004–7
- Dalakas M C, Pezeshkpour G H, Gravell M, Sever J L. Polymyositis associated with AIDS retrovirus. JAMA 1986; 256: 2381–3
- Evans B K, Gore I, Harrell L E, Arnold T, Oh S J. HTLV-I-associated myelopathy and polymyositis in a US native. Neurology 1989; 39: 1572–5
- Cassidy J T, Petty R E. Juvenile dermatomyositis. Textbook of Pediatric Rheumatology, 3rd ed. WB Saunders Co., Philadelphia 1995; 323–64
- Bennett M R, O'Connor H J, Neuberger J M, Elias E. Acute polymyositis in an adult associated with Mycoplasma pneumoniae infection. Postgrad Med J 1990; 66: 47–8
- Biberfeld G, Gronowicz E. Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature 1976; 261: 238–9
- Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin exp Immunol 1971; 8: 319–33
- Salazar M, Yunis E J. MHC: Gene structure and function. Samter's Immunologic diseases. 5th ed, MM et al. Frank. Little, Brown and Company, Boston 1995; Vol. 1: 101–16
- Bohan A, Peter J B, Bowman RL., Pearson C M. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255–86
- Miller L C, Sisson B A, Tucker L B, DeNardo B A, Schaller J G. Methotrexate treatment of recalcitrant childhood dermatomyositis. Arthritis Rheum 1992; 35: 1143–9